This document reports on Dr. Montalescot's research grants and consulting/lecture fees from various pharmaceutical companies. It discloses potential conflicts of interest from his relationships with ADIR, Amgen, AstraZeneca, Bayer, Berlin Chimie AG, Boehringer Ingelheim, Bristol-Myers Squibb, and several other companies.